Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Multicenter Trial of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

NCT01002092 is registered in ClinicalTrials.gov with Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd as lead sponsor.

NCT NCT01002092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01002092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Multicenter Trial of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Lead sponsor
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2009
Completion date
December 31, 2014
Enrollment
160 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma